CareLit · DOI-Nachweis · Klinische Pädiatrie
The DC activation marker CD83 binds to a CD4+ subpopulation of PBMC – options for immune therapy
DOI 10.1055/s-2004-828577
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Jenner, A Staiber, R Handgretinger, D Niethammer, I Müller
ZeitschriftKlinische Pädiatrie
Ausgabe05/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Dendritic cells (DC) have been used in clinical trials for immune therapy of various malignancies. However, activation strategies for DC to date have been insufficient to mount a curative T cell response. We started to investigate the stimulatory DC maturation marker CD83, whose ligand is unknown. We cloned the extracellular domain of CD83 and expressed it in eukaryotic cells to obtain a physiologically glycosylated…
Zitieren
Zitierempfehlung
J Jenner, A Staiber, R Handgretinger, D Niethammer, I Müller (2004) The DC activation marker CD83 binds to a CD4+ subpopulation of PBMC – options for immune therapy. Klinische Pädiatrie (05). https://doi.org/10.1055/s-2004-828577
Mit CareLit weiterarbeiten